C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.
about
Modulating Behavior in C. elegans Using Electroshock and Antiepileptic DrugsAn ultra high-throughput, whole-animal screen for small molecule modulators of a specific genetic pathway in Caenorhabditis elegansGenetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models.MORPHIN: a web tool for human disease research by projecting model organism biology onto a human integrated gene network.Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organismsIlex paraguariensis Extract Increases Lifespan and Protects Against the Toxic Effects Caused by Paraquat in Caenorhabditis elegansHuman disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.A new role for laminins as modulators of protein toxicity in Caenorhabditis elegans.Mitochondrial dysfunction in genetic animal models of Parkinson's diseasePhenotypic screens for compounds that target the cellular pathologies underlying Parkinson's diseaseSteroid Androgen Exposure during Development Has No Effect on Reproductive Physiology of Biomphalaria glabrata.Synthesis and neuroprotective action of xyloketal derivatives in Parkinson's disease models.Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death.Neurodegenerative disorders: insights from the nematode Caenorhabditis elegansMulti-step usage of in vivo models during rational drug design and discovery.Cell and small animal models for phenotypic drug discovery.Limitations of animal models of Parkinson's disease.Age- and manganese-dependent modulation of dopaminergic phenotypes in a C. elegans DJ-1 genetic model of Parkinson's disease.Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseasesVirulence test using nematodes to prescreen Nocardia species capable of inducing neurodegeneration and behavioral disorders.Structural Biology of the DJ-1 Superfamily.Modeling Host-Microbiome Interactions in Caenorhabditis elegans.Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease.The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity.Genome-Wide RNA Interference: Functional Genomics in the Postgenomics Era.A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans.
P2860
Q27321178-82A739FB-C5A2-44D4-AFF2-249684413180Q28487176-7C1559BC-0FA5-4A4D-B536-79456A8FCBF8Q33729960-2023B694-B49A-4D1F-992F-57703C38024CQ33790301-D3D0A312-E1AC-4BF1-B5F2-4EE04BE3016CQ33860799-CF3C8054-66F0-4323-B99B-3F93BC097F4EQ34158629-B316C621-8646-4267-9A83-2073DCECA5DDQ34411943-34D89F64-1C64-44A9-87D8-A337862DE428Q34858502-9AED8710-26F4-42C3-8E8A-5CC312C6EEBDQ35589979-941BF19A-BE1D-423D-9EBA-6682FE72315FQ35670325-3509A2C4-2B67-4ED5-9696-629F54202D29Q35799109-145646B0-33CC-46F1-B6BB-2A5C99526721Q36810598-37559872-3F3F-4280-8E71-6DA64B41A74CQ37119151-92919B90-7866-4D4E-BE96-5BC65F47A6C8Q37425008-2A57CDE0-9927-4CBA-9BBD-4341190DBCFFQ37717607-C272AB15-515E-4095-B538-E571A389C9C4Q37759354-2E74EE1D-F27C-4A09-8CA5-C3874AB4A948Q37897957-0AE181FE-7318-49F9-8932-7F4AD97EDE56Q39442815-53809304-D544-4A70-8647-F1483AEA6AB0Q41488512-1AF33943-33A9-4547-918A-506D3BC96F84Q41659850-D0466DA2-F904-4516-8BE5-A74E18976FC0Q41863882-FA737928-D51C-46E8-9954-05B8A81FD280Q42376698-122F1FEC-531A-48A1-AFB9-843E5386620AQ47393169-A4BC08E8-174E-4883-B9BD-4625A1532284Q49403382-74F3E4F7-DC68-44CF-ABC6-7FDCBA304117Q49484191-40F70BB5-6A66-4965-9622-300D01723AB8Q50048940-19AF8E02-752B-47F0-BB73-43331C4279E9Q50231596-D4660E6E-ABCD-44E6-B3D0-EB027A8BDA7FQ52839974-4483A3BF-6597-4DDB-B7C4-4F259EA5E4C0
P2860
C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
C. elegans as a model organism ...... lved with Parkinson's disease.
@en
C. elegans as a model organism ...... lved with Parkinson's disease.
@nl
type
label
C. elegans as a model organism ...... lved with Parkinson's disease.
@en
C. elegans as a model organism ...... lved with Parkinson's disease.
@nl
prefLabel
C. elegans as a model organism ...... lved with Parkinson's disease.
@en
C. elegans as a model organism ...... lved with Parkinson's disease.
@nl
P2093
P356
P1476
C. elegans as a model organism ...... olved with Parkinson's disease
@en
P2093
Guy A Caldwell
Kim A Caldwell
Shusei Hamamichi
P2860
P304
P356
10.1002/DVDY.22231
P577
2010-05-01T00:00:00Z